Nutrition 21 ( NXXI) soared 22% Tuesday after the company said a study showed its Selenomax product stopped progression of the HIV virus.

The Purchase, N.Y., company said the benefits were reported in a five-year, double-blind, placebo-controlled study conducted by researchers at the University of Miami and published in the Jan. 22 issue of the American Medical Association's Archives of Internal Medicine.

Shares were rising 41 cents to $2.30.

If you liked this article you might like

Spain to Play Netherlands for World Cup

Spain to Play Netherlands for World Cup

Wal-Mart: Analysts' Upgrades, Downgrades

Wal-Mart: Analysts' Upgrades, Downgrades

Netherlands Advances to World Cup Final

Netherlands Advances to World Cup Final

Apple: Analysts' Upgrades, Downgrades

Apple: Analysts' Upgrades, Downgrades

World Markets Mostly Lower Monday

World Markets Mostly Lower Monday